Search research articles
Contact Us
Filters
Showing results (11-20 of 170) with videos related to
Page
of 17
Sort By:
Neurotoxicology
|
January 1, 1990
Neurochemical basis of neurotoxicity
J W Gibb, M Johnson, G R Hanson
The Journal of Pharmacology and Experimental Therapeutics
|
November 14, 1997
Exacerbation of methamphetamine-induced neurochemical deficits by melatonin
J W Gibb, L Bush, G R Hanson
Biochemical Pharmacology
|
December 1, 1989
Characterization of acute N-ethyl-3,4-methylenedioxyamphetamine (MDE) action on the central serotonergic system
M Johnson, G R Hanson, J W Gibb
Neuropharmacology
|
June 1, 1991
Norepinephrine does not contribute to methamphetamine-induced changes in hippocampal serotonergic system
M Johnson, G R Hanson, J W Gibb
Biochemical Society Transactions
|
October 10, 1998
Dimethylsulphoxide reductase from purple phototrophic bacteria: structures and mechanism(s)
A G McEwan, G R Hanson, S Bailey
Neuropharmacology
|
November 1, 1988
Effects of dopaminergic and serotonergic receptor blockade on neurochemical changes induced by acute administration of methamphetamine and 3,4-methylenedioxymethamphetamine
M Johnson, G R Hanson, J W Gibb
Biochemical Pharmacology
|
December 1, 1987
Effects of N-ethyl-3,4-methylenedioxyamphetamine (MDE) on central serotonergic and dopaminergic systems of the rat
M Johnson, G R Hanson, J W Gibb
European Journal of Pharmacology
|
December 8, 2000
Methamphetamine decreases mouse striatal dopamine transporter activity: roles of hyperthermia and dopamine
V Sandoval, G R Hanson, A E Fleckenstein
NIDA Research Monograph
|
January 1, 1989
MK-801 attenuates the methamphetamine induced decreased in tryptophan hydroxylase activity
J W Gibb, M Johnson, G R Hanson
European Journal of Pharmacology
|
June 20, 1989
Effect of MK-801 on the decrease in tryptophan hydroxylase induced by methamphetamine and its methylenedioxy analog
M Johnson, G R Hanson, J W Gibb
Page
of 17
Search research articles
Search
Showing results (11-20 of 170) with videos related to
Sort By:
Page
of 17
Neurotoxicology
|
January 1, 1990
Neurochemical basis of neurotoxicity
J W Gibb, M Johnson, G R Hanson
The Journal of Pharmacology and Experimental Therapeutics
|
November 14, 1997
Exacerbation of methamphetamine-induced neurochemical deficits by melatonin
J W Gibb, L Bush, G R Hanson
Biochemical Pharmacology
|
December 1, 1989
Characterization of acute N-ethyl-3,4-methylenedioxyamphetamine (MDE) action on the central serotonergic system
M Johnson, G R Hanson, J W Gibb
Neuropharmacology
|
June 1, 1991
Norepinephrine does not contribute to methamphetamine-induced changes in hippocampal serotonergic system
M Johnson, G R Hanson, J W Gibb
Biochemical Society Transactions
|
October 10, 1998
Dimethylsulphoxide reductase from purple phototrophic bacteria: structures and mechanism(s)
A G McEwan, G R Hanson, S Bailey
Neuropharmacology
|
November 1, 1988
Effects of dopaminergic and serotonergic receptor blockade on neurochemical changes induced by acute administration of methamphetamine and 3,4-methylenedioxymethamphetamine
M Johnson, G R Hanson, J W Gibb
Biochemical Pharmacology
|
December 1, 1987
Effects of N-ethyl-3,4-methylenedioxyamphetamine (MDE) on central serotonergic and dopaminergic systems of the rat
M Johnson, G R Hanson, J W Gibb
European Journal of Pharmacology
|
December 8, 2000
Methamphetamine decreases mouse striatal dopamine transporter activity: roles of hyperthermia and dopamine
V Sandoval, G R Hanson, A E Fleckenstein
NIDA Research Monograph
|
January 1, 1989
MK-801 attenuates the methamphetamine induced decreased in tryptophan hydroxylase activity
J W Gibb, M Johnson, G R Hanson
European Journal of Pharmacology
|
June 20, 1989
Effect of MK-801 on the decrease in tryptophan hydroxylase induced by methamphetamine and its methylenedioxy analog
M Johnson, G R Hanson, J W Gibb
Page
of 17